Generic and Biosimilar Patent Landscape
Wednesday, November 9, 2022
11:00 a.m. - 12:30 p.m.
Various proposals are being considered to amend and reform patent law. This panel will discuss these proposals to amend IPR and potential changes to obviousness-type double patenting, section 101 of the Patent Act, and how patent litigation proceeds.
Moderator: Robert Cerwinski, JD
Managing Partner, Gemini Law LLP
Aziz Burgy, JD, MS
Partner, Axinn, Veltrop & Harkrider LLP
Rachel Goode, PhD
Senior Vice President, IP and Legal, Biosimilars, Fresenius Kabi USA
Sara Koblitz, JD
Director, Hyman, Phelps, & McNamara, P.C.